このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

IHH Healthcare Berhad マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Prem Kumar Nair

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	2.6yrs
取締役会の平均在任期間	1.3yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Prem Kumar Nair (63 yo)

less than a year

在職期間

Dr. Prem Kumar Nair serves as Non-Executive Director of Parkway Trust Management Limited a Manager of Parkway Life Real Estate Investment Trust since November 17, 2023. He serves as Non-Executive & Non-Ind...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Prem Kumar Nair	Group Chief Executive Officer	less than a year	データなし	データなし
Dilip Kadambi	Group Chief Financial Officer	less than a year	データなし	データなし
Penelope Koh	Vice President of Investor Relations	no data	データなし	データなし
Nili Shayrina Saat	Group Head of Risk Management & Compliance	1.4yrs	データなし	データなし
Ida binti Ab Rahim	Group General Counsel & Company Secretary	5yrs	データなし	データなし
Stephen Byrne	Group Head of Internal Audit	3.4yrs	データなし	データなし
Ashok Pandit	Group Chief Corporate Officer	2.8yrs	データなし	データなし
Jean-Francois Naa	Chief Executive Officer of HH Healthcare Malaysia	4.3yrs	データなし	データなし
Zhiping Li	Chief Executive Officer of IHH Healthcare China	3.7yrs	データなし	データなし
Anurag Yadav	Chief Executive Officer of IHH Healthcare India	2.4yrs	データなし	データなし
Chorng Ann Chow	Chief Executive Officer of IHH Healthcare Singapore	less than a year	データなし	データなし
Kenneth Tsang	Regional Chief Executive Officer of IHH Healthcare North Asia	no data	データなし	データなし

2.6yrs

平均在職期間

53.5yo

平均年齢

経験豊富な経営陣: Q0Fの経営陣は経験豊富であると考えられます ( 2.6年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Yoichiro Endo	Non-Independent Non-Executive Director	less than a year	データなし	データなし
Muthanna Bin Abdullah	Independent Non-Executive Director	no data	RM660.00k	データなし
Satoshi Tanaka	Independent Non-Executive Director	no data	RM485.00k	データなし
Mehmet Aydinlar	Non-Independent & Non-Executive Director	12.4yrs	RM385.00k	0.17% MYR 26.8m
Jill Watts	Independent Non-Executive Director	no data	RM660.00k	データなし
Mohd Bin Mohd Harris	Non-Independent & Non-Executive Director	1.3yrs	データなし	データなし
Tomo Nagahiro	Non-Independent & Non-Executive Director	1.3yrs	データなし	データなし
Tsin-Lin Lim	Non Independent Non Executive Director	1.3yrs	データなし	データなし
Jia Mok	Non Independent & Non Executive Alternate Director	1.3yrs	データなし	データなし

1.3yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: Q0Fの取締役会は経験豊富ではない ( 1.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

IHH Healthcare Berhad マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Recent updates

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: RM0.087 (vs RM0.16 in 1Q 2023)

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

IHH Healthcare Berhad to Report Q1, 2024 Results on May 29, 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Upcoming dividend of RM0.055 per share

Dividend of RM0.055 announced

Full year 2023 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad to Report Q4, 2023 Results on Feb 29, 2024

IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer

Third quarter 2023 earnings released: EPS: RM0.06 (vs RM0.028 in 3Q 2022)

IHH Healthcare Berhad to Report Q3, 2023 Results on Nov 30, 2023

IHH Healthcare Berhad Announces Joerg Ayrle, Group Chief Financial Officer to Remain on Garden Leave, Effective from 30 September 2023

Upcoming dividend of RM0.035 per share at 1.2% yield

IHH Healthcare Berhad Declares Interim Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: RM0.034 (vs RM0.067 in 2Q 2022)

IHH Healthcare Berhad to Report Q2, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: RM0.16 (vs RM0.054 in 1Q 2022)

Upcoming dividend of RM0.096 per share at 1.2% yield

IHH Healthcare Berhad to Report Q1, 2023 Results on May 31, 2023

IHH Healthcare Berhad Announces Special Cash Dividend, Payable on 30 June 2023

High number of new directors

Upcoming dividend of RM0.07 per share at 1.2% yield

Full year 2022 earnings released: EPS: RM0.17 (vs RM0.20 in FY 2021)

IHH Healthcare Berhad Announces Appointment of Mr. Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces Resignation of Farid Bin Mohamed Sani as Non Independent and Non Executive Director

IHH Healthcare Berhad Appoints Tomo Nagahiro as Non-Independent and Non-Executive Director

IHH Healthcare Berhad to Report Q4, 2022 Results on Feb 28, 2023

IHH Healthcare Berhad Announces the Resignation of Tomo Nagahiro as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces the Cessation of Takeshi Saito as Member of Nomination and Remuneration Committee, Effective January 27, 2023

Third quarter 2022 earnings released: EPS: RM0.028 (vs RM0.06 in 3Q 2021)

IHH Healthcare Berhad to Report Q3, 2022 Results on Nov 29, 2022

United States Federal District Court Grants IHH Healthcare Berhad Motion to Dismiss Emqore Amended Complaint

Second quarter 2022 earnings released: EPS: RM0.067 (vs RM0.053 in 2Q 2021)

IHH Healthcare Berhad Reports Write Offs for the Second Quarter Ended June 30, 2022

IHH Healthcare Berhad to Report Q2, 2022 Results on Aug 25, 2022

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for a total enterprise value of MYR 1345 million.

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for MYR 1345 million.

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

IHH Healthcare Berhad to Report Q1, 2022 Results on May 26, 2022

Now 20% undervalued

High number of new directors

Now 22% undervalued after recent price drop

Permodalan Nasional Reportedly Looking to Dispose of A Portion of Its Shares in IHH Healthcare and Petronas Chemicals Group

IHH Healthcare Berhad Provides Update on Material Litigation

Upcoming dividend of RM0.06 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad Reports Impairment for the Fourth Quarter Ended December 31, 2021

IHH Healthcare Berhad Announces the Resignation of Wong Eugene as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Fortis Healthcare Limited Updates on Its Complaint

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2021 earnings released: EPS RM0.053 (vs RM0.016 loss in 2Q 2020)

First quarter 2021 earnings released: EPS RM0.04 (vs RM0.039 loss in 1Q 2020)

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Mitsui Reportedly Explores Deal to Take IHH Healthcare as Private

Full year 2020 earnings released: EPS RM0.023 (vs RM0.053 in FY 2019)

Upcoming dividend of RM0.04 per share

Shriram Vijayakumar Appoints as CEO of IHH Healthcare India

Full year 2020 earnings released: EPS RM0.023 (vs RM0.053 in FY 2019)

Revenue beats expectations

マネジメント基準チェック /14